Shenzhen YHLO Biotech Future Growth
Future criteria checks 5/6
Shenzhen YHLO Biotech is forecast to grow earnings and revenue by 30.8% and 23.1% per annum respectively. EPS is expected to grow by 30.3% per annum. Return on equity is forecast to be 18.5% in 3 years.
Key information
30.8%
Earnings growth rate
30.3%
EPS growth rate
| Medical Equipment earnings growth | 23.9% |
| Revenue growth rate | 23.1% |
| Future return on equity | 18.5% |
| Analyst coverage | Good |
| Last updated | 19 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?
Jul 18
Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing
May 23Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 01There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital
Mar 19Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3,509 | 833 | N/A | 831 | 4 |
| 12/31/2025 | 2,798 | 644 | N/A | 712 | 7 |
| 12/31/2024 | 2,238 | 481 | N/A | 715 | 6 |
| 3/31/2024 | 1,824 | 340 | -339 | 359 | N/A |
| 12/31/2023 | 2,053 | 355 | -736 | -73 | N/A |
| 9/30/2023 | 2,397 | 424 | -333 | 292 | N/A |
| 6/30/2023 | 2,719 | 488 | -214 | 419 | N/A |
| 3/31/2023 | 3,271 | 582 | 66 | 663 | N/A |
| 12/31/2022 | 3,981 | 1,012 | 1,018 | 1,583 | N/A |
| 9/30/2022 | 3,450 | 923 | 412 | 933 | N/A |
| 6/30/2022 | 2,967 | 782 | 381 | 816 | N/A |
| 3/31/2022 | 2,312 | 678 | 501 | 813 | N/A |
| 12/31/2021 | 1,178 | 205 | -113 | 260 | N/A |
| 9/30/2021 | 1,147 | 216 | -45 | 253 | N/A |
| 6/30/2021 | 1,118 | 198 | -26 | 230 | N/A |
| 3/31/2021 | 1,020 | 198 | -38 | 230 | N/A |
| 1/1/2021 | 999 | 211 | 93 | 282 | N/A |
| 12/31/2019 | 877 | 108 | -60 | 68 | N/A |
| 12/31/2018 | 729 | 38 | -157 | 30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688575's forecast earnings growth (30.8% per year) is above the savings rate (2.9%).
Earnings vs Market: 688575's earnings (30.8% per year) are forecast to grow faster than the CN market (16.8% per year).
High Growth Earnings: 688575's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688575's revenue (23.1% per year) is forecast to grow faster than the CN market (10.4% per year).
High Growth Revenue: 688575's revenue (23.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688575's Return on Equity is forecast to be low in 3 years time (18.5%).